Save 96% on an unlimited web hosting lifetime with iBrave


Multiple Monitors

TL; DR: A lifetime subscription to iBrave Cloud Web Hosting is on sale for £82.53, saving you 96% off the list price.

Finding a good web host for your website is like finding a good home for yourself. You more than likely want somewhere safe, reliable, and hopefully not too expensive. Normally, hosting prices are monthly. However, if you plan to stay a long time, finding a host that fits your criteria and only requires one payment for lifetime access could save you a lot.

This is where iBrave Cloud web hosting comes in. For a limited time, you can get a lifetime subscription with this web hosting service that bundles a lot of tools and features into your subscription, and it’s currently only £82.53.

Starting off, a lifetime of web hosting for a fixed price is a tough deal to beat if you plan to keep your website online for more than a few months. However, iBrave also gives you a few tools and features that might be useful for site migration and management. With your lifetime subscription, you also get iBrave’s free website builder tools and one-click migration from WordPress, Magento, Joomla, or over 80 other popular website builders.

If you have multiple websites, you can host them all with iBrave. Your subscription gives you unlimited hosting, but you must provide the domain name each time. However, you get unlimited subdomains, monthly bandwidth, SSD storage, MySQL databases, and personalized email addresses.

In terms of your site security, iBrave has built-in anti-virus and anti-spam protection, giving you access to iBrave’s secure data centers. If you need help managing one of your sites, you can also call the helpline available every day.

Get a host that lasts a lifetime. For a limited time, get iBrave Cloud Web Hosting Lifetime Subscription on sale for £82.53.

Course logo

Course Logo

Credit: iBrave

iBrave Cloud Web Hosting (Lifetime Subscription) (opens in a new tab)

£82.53 at the Mashable store

(opens in a new tab)


Comments are closed.